Fortitude Family Office, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Fortitude Family Office, LLC
- $372 Billion
- Q3 2025
A detailed history of Fortitude Family Office, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Fortitude Family Office, LLC holds 235 shares of EYPT stock, worth $2,930. This represents 0.0% of its overall portfolio holdings.
Number of Shares
235
Previous 235
-0.0%
Holding current value
$2,930
Previous $2.21 Million
51.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EYPT
# of Institutions
162Shares Held
67.2MCall Options Held
214KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$104 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$84.8 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$84.8 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.6MShares$57.4 Million0.09% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$53.6 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $425M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...